Functional diversity in the gene network controlled by the master regulator p53 in humans

Cell Cycle

Volumn 4, Issue 8, 2005, Pages 1026-1029

  Resnick, Michael A ^a   Tomso, Dan ^a   Inga, Alberto ^a,b   Menendez, Daniel ^a   Bell, Douglas ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Master regulator; Mutation; p53; SNP; Transcription

Indexed keywords

DNA; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN;

ACETYLATION; BIOINFORMATICS; DISEASE MARKER; DNA SEQUENCE; FUNCTIONAL PROTEOMICS; GENE CONTROL; GENE INTERACTION; GENETIC REGULATION; GENETIC RISK; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; PROMOTER REGION; REGULATOR GENE; RISK ASSESSMENT; SEQUENCE ANALYSIS; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSACTIVATION; TUMOR SUPPRESSOR GENE;

EID: 25444472045     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.4.8.1904     Document Type: Short Survey

References (31)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57-70.
2. Darnell Jr JE. Transcription factors as targets for cancer therapy. Nat Rev Cancer 2002; 2:740-9.
3. Futcher B. Transcriptional regulatory networks and the yeast cell cycle. Curr Opin Cell Biol 2002; 14:676-83.
4. Resnick MA, Inga A. Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity. Proc Natl Acad Sci USA 2003; 100:9934-9.
5. Babu MM, Luscombe NM, Aravind L, Gerstein M, Teichmann SA. Structure and evolution of transcriptional regulatory networks. Curr Opin Struct Biol 2004; 14:283-91.
6. Inga A, Storici F, Darden TA, Resnick MA. Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter target sequence. Mol Cell Biol 2002; 22:8612-25.
7. Kim JT, Gewehr JE, Martinetz T. Binding matrix: A novel approach for binding site recognition. J Bioinform Comput Biol 2004; 2:289-307.
8. Long F, Liu H, Hahn C, Sumazin P, Zhang MQ, Zilberstein A. Genome-wide prediction and analysis of function-specific transcription factor binding sites. In Silico Biol 2004; 4:395-410.
9. Wingender E. TRANSFAC, TRANSPATH and CYTOMER as starting points for an ontology of regulatory networks. In Silico Biol 2004; 4:55-61.
10. Marinescu VD, Kohane IS, Riva A. MAPPER: A search engine for the computational identification of putative transcription factor binding sites in multiple genomes. BMC Bioinformatics 2005; 6:79.
11. Tomso DJ, Inga A, Menendez D, Pittman GS, Campbell M R, Storici F, Bell DA, Resnick MA. Functionally distinct polymorphic sequences in the human genome that are targets for p53 transactivation. Proc Natl Acad Sci USA 2005; 102:6431-6.
12. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408:307-10.
13. Meek DW. The p53 response to DNA damage. DNA Repair (Amst) 2004; 3:1049-56.
14. Harris SL, Levine AJ. The p53 pathway: Positive and negative feedback loops. Oncogene 2005; 24:2899-908.
15. Marcus PM, Hayes RB, Vineis P, Garcia-Closas M, Caporaso NE, Autrup H, Branch RA, Brockmoller J, Ishizaki T, Karakaya AE, Ladero JM, Mommsen S, Okkels H, Romkes M, Roots I, Rothman, N. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: A case-series meta-analysis of a gene-environment interaction. Cancer Epidemiol Biomarkers Prev 2000; 9:461-7.
16. Boccia LM, Lillicrap D, Newcombe K, Mueller CR. Binding of the Ets factor GA-binding protein to an upstream site in the factor IX promoter is a critical event in transactivation. Mol Cell Biol 1996; 16:1929-35.
17. Vasiliev GV, Merkulov VM, Kobzev VF, Merkulova TI, Ponomarenko MP, Kolchanov NA. Point mutations within 663-666 bp of intron 6 of the human TDO2 gene, associated with a number of psychiatric disorders, damage the YY-1 transcription factor binding site. FEBS Lett 1999; 462:85-8.
18. Liu X, Campbell MR, Pittman GS, Faulkner EC, Watson MA, Bell DA. Expression-based discovery of variation in the human glutathione S-transferase M3 promoter and functional analysis in a glioma cell line using allele-specific chromatin immunoprecipitation. Cancer Res 2005; 65:99-104.
19. Piedrafita FJ, Molander RB, Vansant G, et al. An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J Biol Chem 1996; 271:14412-20.
20. Knight JC, Udalova I, Hill AV, et al. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet 1999; 22:145-50.
21. el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B. Definition of a consensus binding site for p53. Nat Genet 1992; 1:45-9.
22. Scharer E, Iggo R. Mammalian p53 can function as a transcription factor in yeast. Nucleic Acids Res 1992; 20:1539-45.
23. Flaman JM, Frebourg T, Moreau V, Charbonnier F, Martin C, Chappuis P, Sappino P, Limacher JM, Bron L, Benhattar J, Tada M, Van Meir EG, Estreicheru A, Iggo RD. A simple p53 functional assay for screening cell lines, blood, and tumors. Proc Natl Acad Sci USA 1995; 92:3963-7.
24. Kennedy BK. Mammalian transcription factors in yeast: Strangers in a familiar land. Nat Rev Mol Cell Biol 2002; 3:41-9.
25. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P. The IARC TP53 database: New online mutation analysis and recommendations to users. Hum Mutat 2002; 19:607-14.
26. Soussi T, Kato S, Levy PP, Ishioka C. Reassessment of the TP53 mutation database in human disease by data mining with a library of TP53 missense mutations. Hum Mutat 2005; 25:6-17.
27. Inga A, Reamon-Buettner SM, Borlak J, Resnick MA. Functional dissection of sequence-specific NKX2-5 DNA binding domain mutations associated with human heart septation defects using a yeast-based system. Hum Mol Genet 2005; in press.
28. Udalova IA, Richardson A, Denys A, Smith C, Ackerman H, Foxwell B, Kwiatkowski D. Functional consequences of a polymorphism affecting NF-kappaB p50-p50 binding to the TNF promoter region. Mol Cell Biol 2000; 20:9113-9.
29. Leung TH, Hoffmann A, Baltimore D. One nucleotide in a kappaB site can determine cofactor specificity for NF-kappaB dimers. Cell 2004; 118:453-64.
30. Udalova IA, Mott R, Field D, Kwiatkowski D. Quantitative prediction of NF-kappa B DNA-protein interactions. Proc Natl Acad Sci USA 2002; 99:8167-72.
31. Gaudet J, Mango SE. Regulation of organogenesis by the Caenorhabditis elegans FoxA protein PHA-4. Science 2002; 295:821-5.